|
Global Med Technologies, Inc. - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Global Med Technologies, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Global Med Technologies, Inc.. The Group's principal activity is to design, develop, market and support information management software products for blood banks, hospitals, centralized transfusion centers and other health care related facilities. It provides blood and laboratory software systems and services and is products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories. Its core products include: SafeTrace(R), SafeTrace Tx(R), and our ElDoradoTM product suite. SafeTrace is used to assist community blood centers, hospitals, plasma centers and outpatient clinics. SafeTrace Tx provides electronic cross-matching capabilities to help insure blood compatibility with patient-recipients and tracks, inventories, bills and documents all activities with blood products. It operates in the United States, Canada, European Union and Africa.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
